Bugs as drugs for cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review.MedComm · 2024
   Review
2. Bacterial cancer therapy using the attenuated fowl-adaptedMolecular therapy oncolytics · 2023
   Article
3. Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions.Frontiers in microbiology · 2018
   Article
4. Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice.BMC cancer · 2015
   Article
5. TLR3 agonists and proinflammatory antitumor activities.Expert opinion on therapeutic targets · 2013
   Article
6. The application of Toll like receptors for cancer therapy.International journal of biological sciences · 2010
   Review
7. Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?British journal of cancer · 2006
   Review
8. Closely related mycobacterial strains demonstrate contrasting levels of efficacy as antitumor vaccines and are processed for major histocompatibility complex class I presentation by multiple routes in dendritic cells.Infection and immunity · 2005
   Article
9. Microbial-based therapy of cancer: current progress and future prospects.Bioengineered bugs
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as